Author

Liudmila Elagina

Broad Institute

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioinformatics· 1 Genomics· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:differential expression· 2 Research Focus:gene regulatory network inference· 2 Organism:human· 2 Approach:statistical model· 2 Assay:whole-exome sequencing· 2 Assay:bulk RNA-seq· 1 Research Focus:trajectory inference· 1 Research Focus:variant calling· 1

Frequent Co-Authors

Chip StewartiD· 2 shared Daniel RosebrockiD· 2 shared Dimitri G. LivitziD· 2 shared Gad A. GetziD· 2 shared Ignaty LeshchineriD· 2 shared Jaegil KimiD· 2 shared Oliver Spiro· 2 shared Aina Zurita MartineziD· 1 shared

Activity by Year

2019-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 43 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersGenomics

Chip StewartORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

GenomicsCell Reports MedicinePeer-reviewedFeb 1, 2022

Combined tumor and immune signals from genomes or transcriptomes predict outcomes of checkpoint inhibition in melanoma

Samuel S. Freeman, Moshe Sade-Feldman, Jaegil Kim…·Nir Hacohen

The paper develops DNA- and RNA-based models combining immune and tumor features to predict outcomes of checkpoint inhibition in melanoma.

38 citations

humanwhole-exome sequencing

𝕏 PostBluesky

BioinformaticsbioRxivPreprintFeb 16, 2019

Comprehensive analysis of tumour initiation, spatial and temporal progression under multiple lines of treatment

Ignaty Leshchiner, Dimitri G. Livitz, Justin F. Gainor…·Gad A. Getz

PhylogicNDT statistically reconstructs cancer driver timing, subclonal phylogenies, and population dynamics from single- or multi-timepoint sequencing, revealing subtype-specific trajectories and therapy resistance evolution across 498 lung adenocarcinomas.

79 citations

humanwhole-exome sequencing

𝕏 PostBluesky